OxySure Systems is showing sure signs of progress and momentum, as demonstrated by its performance over the past few quarters and data released this week on this year’s second quarter earnings. On August 13, 2013, the company reported its second … Continue reading →

OxySure Systems, a medical technology company that has pioneered an FDA-approved solution to produce medically pure oxygen from dry, inert powders for emergency and short duration use, will be an exhibitor at the National Safety Council’s (NSC) 2013 Congress & … Continue reading →

OxySure Systems, a medical technology company that has pioneered an FDA-approved solution to produce medically pure oxygen from dry, inert powders for emergency/short duration use, this morning gave investors a progress report on the CE Marking of its flagship product, … Continue reading →

Analysts at Sterling Investment Services today reiterated the Buy rating on medical technology company OxySure Systems. The firm set a 12-month price target of $1.90 on OXYS’ common stock. This is the third recently issued Buy rating on OXYS with … Continue reading →

OxySure Systems, a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology today, was recently featured in an interview produced by The Stock Radio. Julian T. Ross, Chairman of the Board and CEO, discussed … Continue reading →

When an industry changing idea comes along, it isn’t long before people start to recognize its importance and wonder why it wasn’t developed earlier. Such is the case with OxySure Systems, inventors of a revolutionary way to supply oxygen for … Continue reading →

OxySure Systems, a medical technology company that has pioneered an FDA-approved solution to produce medically pure oxygen from dry, inert powders for emergency/short duration use, was reiterated with a Speculative Buy rating from analysts at Taglich Brothers. Taglich Brothers set … Continue reading →

Today before the opening bell, QualityStocks announced that a new audio interview with OxySure Systems, Inc. is available. The interview can be heard at http://dtg.fm/OXYS-Interview-08-20. OXYS is a medical technology company that has pioneered a solution to produce medically pure … Continue reading →

Today before the opening bell, OxySure reported its financial and operating results for the second quarter ended June 30, 2013. Second Quarter 2013 Highlights: Total revenue increased by about 657% to $476,071 General and administrative expense down by about 18%      to … Continue reading →

Earlier today, OxySure Systems announced that it will be holding a conference call at 9:00 am ET on Tuesday, August 13, 2013, to discuss its financial results for the three months ended June 30, 2013. CEO Julian Ross will be … Continue reading →